Interactions of intergenic microRNAs with mRNAs of genes involved in carcinogenesis

被引:25
作者
Issabekova, Assel [1 ]
Berillo, Olga [1 ]
Regnier, Mireille [1 ]
Anatoly, Ivashchenko [1 ]
机构
[1] Al Farabi Kazakh Natl Univ, Biol & Biotechnol Dept, Alma Ata 050040, Kazakhstan
关键词
microRNA; mRNA; oncogene; human; oncogenesis;
D O I
10.6026/97320630008513
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
miRNAs regulate gene expression by binding with mRNAs of many genes. Studying their effects on genes involved in oncogenesis is important in cancer diagnostics and therapeutics. The RNAHybrid 2.1 program was used to predict the strong miRNA binding sites (p < 0.0005) in target mRNAs. The program Finder 2.2 was created to verify 784 intergenic miRNAs (ig-miRNA) origin. Among 54 considered oncogenes and tumor suppressor genes, 47 genes are the best targets for ig-miRNAs. Accordingly, these genes are strongly regulated by 111 ig-miRNAs. Some miRNAs bind several mRNAs, and some mRNAs have several binding sites for miRNAs. Of the 54 mRNAs, 21.8%, 43.0%, and 35.2% of the miRNA binding sites are present in the 5'UTRs, CDSes, and 3'UTRs, respectively. The average density of the binding sites for miRNAs in the 5'UTR was 4.4 times and 4.1 times greater than in the CDS and the 3'UTR, respectively. Three types of interactions between miRNAs and mRNAs were identified, which differ according to the region of the miRNA bound to the mRNA: 1) binding occurs predominantly via the 3'-region of the miRNA; 2) binding occurs predominantly through the central region of the miRNA; and 3) binding occurs predominantly via the 5'-region of the miRNA. Several miRNAs effectively regulate only one gene, and this information could be useful in molecular medicine to modulate translation of the target mRNA. We recommend described new sites for validation by experimental investigation.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 27 条
  • [1] Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
    Bishop, Justin A.
    Benjamin, Hila
    Cholakh, Hila
    Chajut, Ayelet
    Clark, Douglas P.
    Westra, William H.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (02) : 610 - 619
  • [2] Catuogno Silvia, 2011, Cancers (Basel), V3, P1877, DOI 10.3390/cancers3021877
  • [3] PKCα mediated induction of miR-101 in human hepatoma HepG2 cells
    Chiang, Chao-Wei
    Huang, Yi
    Leong, Ka-Wai
    Chen, Lih-Chyang
    Chen, Hua-Chien
    Chen, Shu-Jen
    Chou, Chen-Kung
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2010, 17
  • [4] Corney DC, 2008, HISTOL HISTOPATHOL, V23, P1161, DOI 10.14670/HH-23.1161
  • [5] miRNA Biomarkers in Breast Cancer Detection and Management
    Fu, Sidney W.
    Chen, Liang
    Man, Yan-gao
    [J]. JOURNAL OF CANCER, 2011, 2 : 116 - 122
  • [6] NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells
    Galardi, Silvia
    Mercatelli, Neri
    Farace, Maria G.
    Ciafre, Silvia A.
    [J]. NUCLEIC ACIDS RESEARCH, 2011, 39 (09) : 3892 - 3902
  • [7] Reduced MicroRNA-218 Expression Is Associated With High Nuclear Factor kappa B Activation in Gastric Cancer
    Gao, Caiping
    Zhang, Zhiyu
    Liu, Wenzhong
    Xiao, Shudong
    Gu, Weiqi
    Lu, Hong
    [J]. CANCER, 2010, 116 (01) : 41 - 49
  • [8] MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions
    Huang, Shenglin
    Wu, Shunquan
    Ding, Jie
    Lin, Jun
    Wei, Lin
    Gu, Jianren
    He, Xianghuo
    [J]. NUCLEIC ACIDS RESEARCH, 2010, 38 (20) : 7211 - 7218
  • [9] Substrate requirements for let-7 function in the developing zebrafish embryo
    Kloosterman, WP
    Wienholds, E
    Ketting, RF
    Plasterk, RHA
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 (21) : 6284 - 6291
  • [10] Tissue-Specific Target Analysis of Disease-Associated MicroRNAs in Human Signaling Pathways
    Kowarsch, Andreas
    Marr, Carsten
    Schmidl, Daniel
    Ruepp, Andreas
    Theis, Fabian J.
    [J]. PLOS ONE, 2010, 5 (06):